BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, closed a $2m seed funding.
The round was led by BioX Clan, which specializes in early stage funding for new bioscience technologies, with participation from Seerave Foundation and SOSV.
The company intends to use the funds to complete its prototype biosensor and data modeling platform in preparation for first clinical trials, scheduled for 2020.
Founded in 2018 by Kevin Honaker, co-founder and CEO, and Dr. Jack Gilbert, co-founder and principal investigator, BiomeSense is developing an at-home biosensor to produce continuous gut microbiome data and a cloud-based analytics platform to turn that data into actionable clinical insights. The company provides this solution to scientists studying the microbiome, delivering data and enabling understanding of how short-term changes in the microbiome influence clinical outcomes.
Joining Honaker and Dr. Gilbert as BiomeSense co-founders is Dr. Savas Tay, University of Chicago professor and bioengineer and an expert in microfluidic engineering.